Entropy Neurodynamics Ltd

$0.035

Day Range

$0.000 – $0.000

52 Week Range

$0.000 – $0.046

Volume

0.00

Avg Volume (10D)

1.18M

Market Cap

$57.11M

Price Chart

Market Statistics

Open$0.035

Previous Close$0.035

Day High$0.000

Day Low$0.000

52 Week High$0.046

Valuation

Market Cap57.11M

Shares Outstanding1.63B

Price to Book7.09

Trading Activity

Volume0.00

Value Traded0.00

Bid$0.035 × 113,858

Ask$0.036 × 813,202

Performance

1 Day0.00%

5 Day-5.41%

13 Week-5.41%

52 Week9.38%

YTD6.06%

Technical Indicators

RSI (14)52.65

50-Day SMA$0.034

200-Day SMA$0.034

Entropy Neurodynamics Reports Breakthrough Results from Phase 2a TRP-8802 Study for Treating IBS

Entropy Neurodynamics announces Phase 2a TRP-8802 IBS results: 75% responders, clear gut-brain axis effect; de-risks program ahead of TRP-8803 trials.

By Imelda Cotton··2 min read min read

Biotechnology

Entropy Neurodynamics' TRP-8803 Trial Shows Repeatable Psychedelic Effects in BED Study

Entropy Neurodynamics reports repeatable psychedelic effects in TRP-8803 BED trial; Cohort 2 enrollment advancing; R&D incentives boost cash runway.

By Isla Campbell··1 min read min read

Biotechnology

Entropy Neurodynamics Granted Australian Patent for TRP8803 to Treat Chronic Pain and Psychiatric Conditions

Entropy Neurodynamics (ASX: ENP) granted Australian patent for TRP8803 (IV psilocybin) for chronic pain and neuropsychiatric disorders; protection to 2042.

By Imelda Cotton··1 min read min read